Replies to post #65537 on Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Way above that by year end! As AXAL EU approval gets closer to year end and we start to see signs of potential approval, then biotech investors who play these type of approvals will start to move in very quickly, that in itself will push price up a lot higher.